SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-105860
Filing Date
2020-04-14
Accepted
2020-04-14 08:24:05
Documents
3
Period of Report
2020-04-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d919317d8k.htm 8-K 17159
2 EX-99.1 d919317dex991.htm EX-99.1 16428
3 GRAPHIC g919317g05a85.jpg GRAPHIC 5472
  Complete submission text file 0001193125-20-105860.txt   42566
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 20790113
SIC: 2834 Pharmaceutical Preparations